Clinical Trials Directory

Trials / Completed

CompletedNCT03994861

Dutch Version Fear-Avoidance Component Scale (FACS)

Validation and Reliability of the Dutch Version of the Fear-Avoidance Component Scale (FACS)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Hasselt University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Chronic musculoskeletal disorders such as low back and neck pain are responsible for an enormous global burden. Fear-avoidance (FA) can be a predictor for the transition from subacute to chronic low back pain. In patients with neck pain, those who were less fearful about harming their neck, had higher pain tolerance, which might have a positive impact on their level of disability. A new scale, the Fear-Avoidance Component Scale (FACS) was developed by Neblett, Mayer, Hartzell, Williams and Gatchel (2015) to assess FA. It consists of an all-encompassing set of constructs that more effectively deals with all critical issues of the FA concept than current scales do. Current scales have been criticized because of following findings: limited construct validity, little evidence on treatment responsiveness, a lack of evidence-based cut-off scores and items being too narrow or too general. The new scale comprehensively assesses all cognitive, emotional and behavioral components related to the updated version of the FA model by combining items of well-known scales in context of the FA model with items on one's perception of victimization and blame related to an injury. A Dutch version of the FACS is currently lacking. Subsequently, the aim of this study is to investigate different psychometric properties of the generated Dutch version in patients with musculoskeletal disorders.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAssessment of disability and behavior (by questionnaires)Assessment of disability and behavior (by questionnaires)

Timeline

Start date
2019-08-01
Primary completion
2022-06-01
Completion
2023-06-01
First posted
2019-06-21
Last updated
2023-09-26

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03994861. Inclusion in this directory is not an endorsement.